• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

Company Seeks to Patent Psilocybin for Weight Loss

by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine

Psilocybin has been fast-tracked by the FDA to become a prescription medication in psychedelic-assisted therapy for depression, but now we’re seeing investors line up to support a new indication for the synthetic compound that’s been made famous—in its organic form—by...

Psilocybin therapy 4 times more effective than antidepressants, study finds

by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine

A new study is presenting the first published data from preliminary human trials investigating the effect of psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). The incredibly positive results have been described as just a “taste of things to...

People are paying $10,000 to trip on magic mushrooms at a retreat in Jamaica. But past struggles with safety and staffing show the difficulty of taking psychedelics mainstream.

by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine

MycoMeditations is a psychedelic-retreat company in Treasure Beach, Jamaica, that facilitates 10-day trips where attendees take psychedelic, or “magic,” mushrooms. Recent research has suggested that magic mushrooms, which contain the psychedelic compound...

New company to put psilocybin on dissolvable sublingual strips to help treat depression

by EmpathiCSubstanceS | Nov 8, 2020 | Psychedelic Medicine

There is a magical moment in the pharmaceutical industry when a government approves a new treatment. For companies researching psilocybin, the psychoactive component in psychedelic mushrooms, that moment is now. Late last year, the United States Food and Drug...

Plant Medicine Church in Oakland Gets Raided by Local Police Department

by EmpathiCSubstanceS | Nov 7, 2020 | Psychedelic Medicine

At 1 pm on Thursday, August 13, Zide Door—an entheogenic church in Oakland, California, that recognizes cannabis and psilocybin mushrooms as religious sacraments—was raided by Oakland Police Department (OPD) during parishioner visiting hours. Zide Door wasn’t just any...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

Aug 17, 2022

PY dose dependently increased scores of all 5D-ASC core dimensions. Only one subject reacted with transient anxiety to HD PY. Compared with PL, MD and HD PY led to a 50% reduction of performance in the FAIR test. "General inactivation", "emotional excitability", and...

Altered trajectories in the dynamical repertoire of functional network states under psilocybin

Aug 17, 2022

We found that a FC state closely corresponding to the fronto-parietal control system was strongly destabilized in the psychedelic state, while transitions toward a globally synchronized FC state were enhanced. These differences between brain state trajectories in...

Neuroticism is associated with challenging experiences with psilocybin mushrooms

Aug 17, 2022

CEQ scores were negatively associated with emotional stability scores (the inverse of neuroticism) in Study 1 and positively associated with neuroticism scores in Study 2. Neuroticism may contribute to the strength of challenging experiences with psychedelics in...

Psychedelic Medicine

Psychedelic Use Statistics

Sep 2, 2023

With scientific progress marching on and psychedelic use among adults exploding, the need for creating infrastructure and delivering safe and legal access is already upon us. Recently published data from the annual Monitoring the Future (MTF) survey by the National...

Neuroplasticity Explained

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Mental Health Treatment Options

Sep 2, 2023

A quarter of the world’s population is estimated to be affected by mental health or neurological challenges in their lifetime. In 2014, approximately 20% of U.S. adults had a mental illness and 22.5 million Americans aged 12 or older were in need of treatment for...

Improving the End of Life Experience with Entheogens

Sep 2, 2023

:::In a 2019 study, 55% of families felt their loved one had a “bad death.” By igniting a movement to spark conversations and ask the right questions, we create opportunities for the things people most want – including spending time with those they love, dignity, and...

Veterans’ Psychedelic-Assisted Therapy

Sep 2, 2023

Psychedelic-Assisted Therapy is “a form of treatment that uses a group of substances that temporarily alter perception and mood and may impact numerous cognitive processes.” (Source: Evidence Brief: Psychedelic Medications for Mental Health and Substance Use...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow